Gaël Hédou
Founder chez Sonnet BioTherapeutics CH SA
Profil
Gaël Hédou has founded Sonnet BioTherapeutics CH SA in 2013, where he holds the title of Director.
He was the Chief Executive & Operating Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019.
Dr. Hédou holds a doctorate from the Swiss Federal Institute of Technology and an undergraduate degree from the University of Strasbourg, which he received in 1997.
Postes actifs de Gaël Hédou
| Sociétés | Poste | Début |
|---|---|---|
Sonnet BioTherapeutics CH SA
 Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Founder | 01/01/2013 |
Anciens postes connus de Gaël Hédou
| Sociétés | Poste | Fin |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Chief Executive Officer | 30/06/2019 |
Formation de Gaël Hédou
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of Strasbourg | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
